Genenta Science S.p.A.
GNTA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001838716
No open-market purchases or sales by Genenta Science S.p.A. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $1.33M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Genenta Science S.p.A. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 2 | 4 | +2 |
| Shares | 45.5K | 458.7K | +413.2K (+908.2%) |
| Value | $273.8K | $2.73M | +$2.46M (+898.3%) |
New holders (2)
Institutions that held Genenta Science S.p.A. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Bank Julius Baer & Co. Ltd, Zurich | 412,547 | $2.46M | 0.01% |
| UBS Group AG | 700 | $4.13K | 0.00% |
Sold out (0)
Institutions that held Genenta Science S.p.A. at the end of Q1 2023 and filed for Q2 2023 without it.
None.